Published March, 2024
By Tze Leung Lai and Philip Lavori
Publisher: Taylor & Francis (CRC Press Inc)
Rating: 1.00
Availability: Available
By Tze Leung Lai and Philip Lavori
Publisher: Taylor & Francis (CRC Press Inc)
Rating: 1.00
Availability: Available
This book focuses on current research and methodologies developed for re-engineering cancer clinical trials and also for "hot" areas in drug development trials such as adaptive design, seamless Phase 2-3 trials, and personalized medicine using biomarkers. Background statistical methodology is summarized in the Appendix.
Hardback
€89.59
Published March, 2024
By Vasilis Z. Marmarelis and Professor Vasilis Z. Marmarelis
Publisher: John Wiley & Sons Ltd (John Wiley & Sons Inc)
Series: IEEE Press Series on Biomedical Engineering
Rating: 1.00
Availability: Available
By Vasilis Z. Marmarelis and Professor Vasilis Z. Marmarelis
Publisher: John Wiley & Sons Ltd (John Wiley & Sons Inc)
Series: IEEE Press Series on Biomedical Engineering
Rating: 1.00
Availability: Available
Hardback
€106.88
Published February, 2024
By Shari R. Waldstein, Matthew F. Muldoon, Dennis H. Novack, Herbert Ochitill and Steven Cole
Publisher: Springer (Springer-Verlag New York Inc.)
Rating: 1.00
Availability: Available
By Shari R. Waldstein, Matthew F. Muldoon, Dennis H. Novack, Herbert Ochitill and Steven Cole
Publisher: Springer (Springer-Verlag New York Inc.)
Rating: 1.00
Availability: Available
These fresh reviews of critical topics in undergraduate medical education identified in the 2004 Institute of Medicine report Improving Medical Education are supplemented by web-enhanced learning materials including linked case studies and PDA materials.
Hardback
€831.99
Published February, 2024
By Nelu Grinberg, Nizar Haddad and Shengli Ma
Publisher: Taylor & Francis (CRC Press Inc)
Rating: 1.00
Availability: Available
By Nelu Grinberg, Nizar Haddad and Shengli Ma
Publisher: Taylor & Francis (CRC Press Inc)
Rating: 1.00
Availability: Available
Hardback
€198.40
Published February, 2024
By Anand Narayan Singh, Seema Nayak and Rashmi Rana
Publisher: Elsevier (Academic Press Inc)
Rating: 1.00
Availability: Available
By Anand Narayan Singh, Seema Nayak and Rashmi Rana
Publisher: Elsevier (Academic Press Inc)
Rating: 1.00
Availability: Available
Paperback / softback
€162.56
Published February, 2024
By Jerry W. Swanson and Manjit Matharu
Publisher: Elsevier (Elsevier Science Publishing Co Inc)
Rating: 1.00
Availability: Available
By Jerry W. Swanson and Manjit Matharu
Publisher: Elsevier (Elsevier Science Publishing Co Inc)
Rating: 1.00
Availability: Available
Hardback
€275.20
Published February, 2024
By Jerry W. Swanson and Manjit Matharu
Publisher: Elsevier (Elsevier Science Publishing Co Inc)
Rating: 1.00
Availability: Available
By Jerry W. Swanson and Manjit Matharu
Publisher: Elsevier (Elsevier Science Publishing Co Inc)
Rating: 1.00
Availability: Available
Hardback
€275.20
Published January, 2024
By Chris Sandal-Wilson
Publisher: Cambridge University Press
Rating: 1.00
Availability: Available
By Chris Sandal-Wilson
Publisher: Cambridge University Press
Rating: 1.00
Availability: Available
Bringing together Middle East studies, histories of empire, and the medical humanities, Mandatory Madness offers an innovative and deeply researched new social and cultural history of Palestine before 1948, and a rethinking of the history and archives of psychiatry from a non-Western context under British colonial rule.
Hardback
€128.00
Published January, 2024
By Michael Bresalier
Publisher: Taylor & Francis (Routledge)
Rating: 1.00
Availability: Available
By Michael Bresalier
Publisher: Taylor & Francis (Routledge)
Rating: 1.00
Availability: Available
Hardback
€147.20
Published January, 2024
By Jawed Iqbal
Publisher: Springer (Springer Verlag, Singapore)
Rating: 1.00
Availability: Available
By Jawed Iqbal
Publisher: Springer (Springer Verlag, Singapore)
Rating: 1.00
Availability: Available
Further, the book discusses the recent developments and therapeutic applications of CRISPR-cas9 in gene therapy and the applications of CRISPR/Cas9 in situ correction of disease-causing mutations, loss-of-function mutations, or gain-of-function mutations in various genetic and neuromuscular diseases.
Hardback
€179.19